SCHEMBL6323397

SCHEMBL6323397

Cc1nc2c(=O)n(C)c(=O)n(C)c2nc1C=Cc1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.54
ALDH1A1 P00352 4/20 0.54
HPGD P15428 3/20 0.50
LMNA P02545 2/20 0.50
JAK2 O60674 1/20 0.50
HTT P42858 1/20 0.50
PAX8 Q06710 1/20 0.50
GAA P10253 2/20 0.49
GLA P06280 1/20 0.49
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
POLB P06746 1/20 0.48
MAPT P10636 1/20 0.48
MAPK1 P28482 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
HSD17B10 Q99714 1/20 0.46
ADORA2A P29274 2/20 0.44
MAOB P27338 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6316460 0.81 ALDH1A1 (0.50) KDM4EALDH1A1HPGDLMNAHTT
SCHEMBL6321029 0.76 KDM4E (0.50) KDM4EALDH1A1HPGDLMNAGAA
SCHEMBL5440337 0.76 KDM4E (0.53) KDM4EALDH1A1HPGDLMNAGAA
SCHEMBL6315474 0.76 KDM4E (0.53) KDM4EALDH1A1HPGDLMNAGAA
SCHEMBL5448291 0.73 ALDH1A1 (0.73) KDM4EALDH1A1HPGDLMNAJAK2
SCHEMBL7402395 0.71 ADORA2A (0.76) KDM4EALDH1A1HPGDGLAHSD17B10
SCHEMBL7288931 0.71 ADORA2A (0.76) KDM4EALDH1A1HPGDGLAHSD17B10
SCHEMBL3668402 0.70 KDM4E (1.00) KDM4EALDH1A1HPGDLMNAJAK2
SCHEMBL7526429 0.70 KDM4E (0.78) KDM4EALDH1A1HPGDLMNAJAK2
SCHEMBL28053799 0.69 GRM4 (0.56) KDM4EALDH1A1HPGDLMNAGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6946465-B2 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2005-09-20 US claimed
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2003-12-25 US claimed
US-6946465-B2 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2005-09-20 US disclosed
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives 4 AZA BIOSCIENCE NV (BE) 2003-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030236255-A1 Immunosuppressive effects of pteridine derivatives TPMT, FKBP5, RRP15 KDM4E 1278/4885ALDH1A1 1744/4885HPGD 1752/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.